You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

NASAREL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Nasarel, and what generic alternatives are available?

Nasarel is a drug marketed by Teva Branded Pharm and is included in one NDA.

The generic ingredient in NASAREL is flunisolide. There are twelve drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the flunisolide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Nasarel

A generic version of NASAREL was approved as flunisolide by BAUSCH on February 20th, 2002.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for NASAREL?
  • What are the global sales for NASAREL?
  • What is Average Wholesale Price for NASAREL?
Summary for NASAREL
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 48
Patent Applications: 5,230
DailyMed Link:NASAREL at DailyMed
Drug patent expirations by year for NASAREL

US Patents and Regulatory Information for NASAREL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Branded Pharm NASAREL flunisolide SPRAY, METERED;NASAL 020409-001 Mar 8, 1995 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for NASAREL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teva Branded Pharm NASAREL flunisolide SPRAY, METERED;NASAL 020409-001 Mar 8, 1995 ⤷  Sign Up ⤷  Sign Up
Teva Branded Pharm NASAREL flunisolide SPRAY, METERED;NASAL 020409-001 Mar 8, 1995 ⤷  Sign Up ⤷  Sign Up
Teva Branded Pharm NASAREL flunisolide SPRAY, METERED;NASAL 020409-001 Mar 8, 1995 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for NASAREL

See the table below for patents covering NASAREL around the world.

Country Patent Number Title Estimated Expiration
United Kingdom 1525181 ⤷  Sign Up
Canada 1075228 UTILISATION DE LA FLUNISOLIDE DANS LE TRAITEMENT DES AFFECTIONS RESPIRATOIRES (FLUNISOLIDE TO TREAT RESPIRATORY DISEASES) ⤷  Sign Up
Hong Kong 8580 NEW FORM OF FLUNISOLIDE AND THE USE OF FLUNISOLIDE TO TREAT RESPIRATORY DISEASES ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.